Comprehensive genomic analysis of metastatic pancreatic ductal adenocarcinoma (mPDAC) reveals a significant proportion of clinical actionable aberrations.

Lee, M; Jones, MR; Williamson, L; Topham, JT; Wong, HL; Addison, S; Denroche, R; Jang, GH; Karasinska, J; McGhie, JP; Gill, S; Lim, HJ; Yip, S; Knox, JJ; Gallinger, S; Laskin, JJ; Marra, MA; Jones, SJM; Schaeffer, DF; Renouf, DJ

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):